Researchers have found that a genetic mutation associated with a rare group of blood cancers does not always result in development of the disease. The work provides insight into the initial phases of the disease and may eventually lead to tailored monitoring techniques that improve patient outcomes.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗